Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy

Nephrology Dialysis Transplantation

Volumn 26, Issue 7, 2011, Pages 2387-2390

  Sola Del Valle, David A ^a   Mohan, Sumit ^a   Cheng, Jen Tse ^a   Paragas, Neal A ^a   Sise, Meghan E ^a   D'Agati, Vivette D ^a   Barasch, Jonathan ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

biomarker; HIV associated nephropathy; progressive chronic kidney disease; tubular injury; urinary neutrophil gelatinase associated lipocalin

Indexed keywords

CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG; URINARY NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; ETHNICITY; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HEPATITIS C; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPOCOMPLEMENTEMIA; KIDNEY BIOPSY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ACUTE-PHASE PROTEINS; ADULT; AIDS-ASSOCIATED NEPHROPATHY; ALBUMINURIA; BIOLOGICAL MARKERS; CREATININE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LIPOCALINS; MALE; MIDDLE AGED; PROGNOSIS; PROTEINURIA; PROTO-ONCOGENE PROTEINS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 79959963624     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr258     Document Type: Article

References (31)

1. Atta MG. Diagnosis and natural history of HIV-associated nephropathy. Adv Chronic Kidney Dis 2010; 17: 52-58.
2. Nebuloni M, Barbiano di Belgiojoso G, Genderini A et al. Glomerular lesions in HIV-positive patients: a 20-year biopsy experience from Northern Italy. Clin Nephrol 2009; 72: 38-45.
3. Han TM, Naicker S, Ramdial PK et al. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 2006; 69: 2243-2250. (Pubitemid 43882112)
4. Lucas GM, Lau B, Atta MG et al. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis 2008; 197: 1548-1557. (Pubitemid 351706485)
5. Winston JA, Burns GC, Klotman PE. The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy. Semin Nephrol 1998; 18: 373-377. (Pubitemid 28340461)
6. D'Agati V, Suh JI, Carbone L et al. Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int 1989; 35: 1358-1370. (Pubitemid 19167929)
7. Wyatt CM, Klotman PE. HIV-1 and HIV-associated nephropathy 25 years later. Clin J Am Soc Nephrol 2007; 2Suppl 1S20-S24.
8. Szczech LA, Gupta SK, Habash R et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004; 66: 1145-1152. (Pubitemid 39121021)
9. Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 1999; 55: 1036-1040. (Pubitemid 29100716)
10. Gupta SK, Eustace JA, Winston JA et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40: 1559-1585. (Pubitemid 40720806)
11. Cohen SD, Kimmel PL. Renal biopsy is necessary for the diagnosis of HIV-associated renal diseases. Nat Clin Pract Nephrol 2009; 5: 22-23.
12. Ross MJ, Klotman PE. HIV-associated nephropathy. AIDS 2004; 18: 1089-1099. (Pubitemid 38738508)
13. Cheng JT, Anderson HLJr, Markowitz GS et al. Hepatitis C virusassociated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol 1999; 10: 1566-1574. (Pubitemid 29297532)
14. Schmidt-Ott KM, Mori K, Li JY et al. Dual Action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2007; 18: 407-413. (Pubitemid 46193306)
15. Bennett M, Dent CL, Ma Q et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008; 3: 665-673.
16. Nickolas TL, O'Rourke MJ, Yang J et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008; 148: 810-819. (Pubitemid 351786928)
17. Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int 2007; 71: 967-970. (Pubitemid 46741985)
18. Suzuki K, Babazono T, Murata H et al. Clinical significance of urinary liver-type fatty acid-binding protein in patients with diabetic nephropathy. Diabetes Care 2005; 28: 2038-2039. (Pubitemid 41060984)
19. Kamijo A, Sugaya T, Hikawa A et al. Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial. J Lab Clin Med 2005; 145: 125-133. (Pubitemid 40432361)
20. Bolignano D, Lacquaniti A, Coppolino G et al. Neutrophil gelatinaseassociated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 337-344.
21. Ju W, Eichinger F, Bitzer M et al. Renal gene and protein expression signatures for prediction of kidney disease progression. Am J Pathol 2009; 174: 2073-2085.
22. Paragas N, Nickolas TL, Wyatt C et al. Urinary NGAL marks cystic disease in HIV-associated nephropathy. J Am Soc Nephrol 2009; 20: 1687-1692.
23. Waikar SS, Sabbisetti VS, Bonventre JV. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int 2010; 78: 486-494.
24. Marras D, Bruggeman LA, Gao F et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIVassociated nephropathy. Nat Med 2002; 8: 522-526. (Pubitemid 34546757)
25. Rao TK, Filippone EJ, Nicastri AD et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984; 310: 669-673. (Pubitemid 14164641)
26. Soler-Garcia AA, Johnson D, Hathout Y et al. Iron-related proteins: candidate urine biomarkers in childhood HIV-associated renal diseases. Clin J Am Soc Nephrol 2009; 4: 763-771.
27. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20: 1-17.
28. Yokoyama T, Kamijo-Ikemori A, Sugaya T et al. Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage. Am J Pathol 2009; 174: 2096-2106.
29. Kamijo A, Sugaya T, Hikawa A et al. Urinary excretion of fatty acidbinding protein reflects stress overload on the proximal tubules. Am J Pathol 2004; 165: 1243-1255. (Pubitemid 39297730)
30. Ding H, He Y, Li K et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol 2007; 123: 227-234. (Pubitemid 46613869)
31. Hall AM, Edwards SG, Lapsley M et al. Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis. Am J Kidney Dis 2009; 54: 1034-1042